Page 67 - Read Online

Siewert JR. Detection of circulating tumor cells in blood using A’Hern R, Levink R, Coumans F, Moreira J, Riisnaes R,
an optimized density gradient centrifugation. Recent Results Oommen NB, Hawche G, Jameson C, Thompson E,
Cancer Res 2003;162:149-55. Sipkema R, Carden CP, Parker C, Dearnaley D, Kaye SB,
11. Muller V, Stahmann N, Riethdorf S, Rau T, Zabel T, Goetz A, Cooper CS, Molina A, Cox ME, Terstappen LW, de Bono JS.
Janicke F, Pantel K. Circulating tumor cells in breast cancer: Characterization of ERG, AR and PTEN gene status in
correlation to bone marrow micrometastases, heterogeneous circulating tumor cells from patients with castration-resistant
response to systemic therapy and low proliferative activity. prostate cancer. Cancer Res 2009;69:2912-8.
Clin Cancer Res 2005;11:3678-85. 26. Leversha MA, Han J, Asgari Z, Danila DC, Lin O,
12. Busch R, Cesar D, Higuera-Alhino D, Gee T, Hellerstein MK, Gonzalez-Espinoza R, Anand A, Lilja H, Heller G, Fleisher M,
McCune JM. Isolation of peripheral blood CD4(+) T cells Scher HI. Fluorescence in situ hybridization analysis
using RosetteSep and MACS for studies of DNA turnover by of circulating tumor cells in metastatic prostate cancer.
deuterium labeling. J Immunol Methods 2004;286:97-109. Clin Cancer Res 2009;15:2091-7.
13. Hayes GM, Busch R, Voogt J, Siah IM, Gee TA, 27. Paris PL, Kobayashi Y, Zhao Q, Zeng W, Sridharan S, Fan T,
Hellerstein MK, Chiorazzi N, Rai KR, Murphy EJ. Isolation Adler HL, Yera ER, Zarrabi MH, Zucker S, Simko J, Chen WT,
of malignant B cells from patients with chronic lymphocytic Rosenberg J. Functional phenotyping and genotyping of
leukemia (CLL) for analysis of cell proliferation: validation of circulating tumor cells from patients with castration resistant
a simplifi ed method suitable for multi-center clinical studies. prostate cancer. Cancer Lett 2009;277:164-73.
Leuk Res 2010;34:809-15. 28. Chen XM, Chen GY, Wang ZR, Zhu FS, Wang XL, Zhang X.
14. McNiece I, Briddell R, Stoney G, Kern B, Zilm K, Detection of micrometastasis of gastric carcinoma in peripheral
Recktenwald D, Miltenyi S. Large-scale isolation of blood circulation. World J Gastroenterol 2004;10:804-8.
CD34+ cells using the amgen cell selection device results in 29. Koga T, Tokunaga E, Sumiyoshi Y, Oki E, Oda S, Takahashi I,
high levels of purity and recovery. J Hematother 1997;6:5-11. Kakeji Y, Baba H, Maehara Y. Detection of circulating gastric
15. Negin BP, Cohen SJ. Circulating tumor cells in colorectal cancer cells in peripheral blood using real time quantitative
cancer: past, present, and future challenges. Curr Treat RT-PCR. Hepatogastroenterology 2008;55:1131-5.
Options Oncol 2010;11:1-13. 30. Pituch-Noworolska A, Kolodziejczyk P, Kulig J, Drabik G,
16. Alunni-Fabbroni M, Sandri MT. Circulating tumour cells Szczepanik A, Czupryna A, Popiela T, Zembala M. Circulating
in clinical practice: methods of detection and possible tumour cells and survival of patients with gastric cancer.
characterization. Methods 2010;50:289-97. Anticancer Res 2007;27:635-40.
17. Iwatsuki M, Mimori K, Fukagawa T, Ishii H, Yokobori T, 31. Soeth E, Vogel I, Roder C, Juhl H, Marxsen J, Kruger U,
Sasako M, Baba H, Mori M. The clinical signifi cance of Henne-Bruns D, Kremer B, Kalthoff H. Comparative analysis
vimentin-expressing gastric cancer cells in bone marrow. Ann of bone marrow and venous blood isolates from gastrointestinal
Surg Oncol 2010;17:2526-33. cancer patients for the detection of disseminated tumor cells
18. Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, using reverse transcription PCR. Cancer Res 1997;57:3106-10.
Nakamori S, Baba H, Mori M. Epithelial-mesenchymal 32. Wu CH, Lin SR, Hsieh JS, Chen FM, Lu CY, Yu FJ,
transition in cancer development and its clinical signifi cance. Cheng TL, Huang TJ, Huang SY, Wang JY. Molecular
Cancer Sci 2010;101:293-9. detection of disseminated tumor cells in the peripheral blood
19. Krivacic RT, Ladanyi A, Curry DN, Hsieh HB, Kuhn P, of patients with gastric cancer: evaluation of their prognostic
Bergsrud DE, Kepros JF, Barbera T, Ho MY, Chen LB, signifi cance. Dis Markers 2006;22:103-9.
Lerner RA, Bruce RH. A rare-cell detector for cancer. 33. Mimori K, Fukagawa T, Kosaka Y, Kita Y, Ishikawa K, Etoh T,
Proc Natl Acad Sci U S A 2004;101:10501-4. Iinuma H, Sasako M, Mori M. Hematogenous metastasis in
20. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, gastric cancer requires isolated tumor cells and expression of
Rao C, Tibbe AG, Uhr JW, Terstappen LW. Tumor cells vascular endothelial growth factor receptor-1. Clin Cancer Res
circulate in the peripheral blood of all major carcinomas but 2008;14:2609-16.
not in healthy subjects or patients with nonmalignant diseases. 34. Arigami T, Uenosono Y, Hirata M, Yanagita S, Ishigami S,
Clin Cancer Res 2004;10:6897-904. Natsugoe S. B7-H3 expression in gastric cancer: a novel
21. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, molecular blood marker for detecting circulating tumor cells.
Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Cancer Sci 2011;102:1019-24.
Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M. 35. Cao W, Yang W, Li H, Lou G, Jiang J, Geng M, Xi W,
Isolation of rare circulating tumour cells in cancer patients by Ren R, Qu Q, Jin X, Zhu Y, Jin Y. Using detection of
microchip technology. Nature 2007;450:1235-9. survivin-expressing circulating tumor cells in peripheral blood
22. Alix-Panabieres C, Brouillet JP, Fabbro M, Yssel H, Rousset T, to predict tumor recurrence following curative resection of
Maudelonde T, Choquet-Kastylevsky G, Vendrell JP. gastric cancer. J Surg Oncol 2011;103:110-5.
Characterization and enumeration of cells secreting tumor 36. Kita Y, Fukagawa T, Mimori K, Kosaka Y, Ishikawa K,
markers in the peripheral blood of breast cancer patients. Aikou T, Natsugoe S, Sasako M, Mori M. Expression of uPAR
J Immunol Methods 2005;299:177-88. mRNA in peripheral blood is a favourite marker for metastasis
23. Alix-Panabieres C, Vendrell JP, Pelle O, Rebillard X, in gastric cancer cases. Br J Cancer 2009;100:153-9.
Riethdorf S, Muller V, Fabbro M, Pantel K. Detection and 37. Kosaka Y, Mimori K, Fukagawa T, Ishikawa K, Etoh T,
characterization of putative metastatic precursor cells in cancer Katai H, Sano T, Watanabe M, Sasako M, Mori M.
patients. Clin Chem 2007;53:537-9. Identifi cation of the high-risk group for metastasis of
24. Alix-Panabieres C, Vendrell JP, Slijper M, Pelle O, Barbotte E, gastric cancer cases by vascular endothelial growth factor
Mercier G, Jacot W, Fabbro M, Pantel K. Full-length receptor-1 overexpression in peripheral blood. Br J Cancer
cytokeratin-19 is released by human tumor cells: a potential 2007;96:1723-8.
role in metastatic progression of breast cancer. Breast Cancer 38. Mimori K, Fukagawa T, Kosaka Y, Ishikawa K, Iwatsuki M,
Res 2009;11:R39. Yokobori T, Hirasaki S, Takatsuno Y, Sakashita H, Ishii H,
25. Attard G, Swennenhuis JF, Olmos D, Reid AH, Vickers E, Sasako M, Mori M. A large-scale study of MT1-MMP as a

136 Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 3 ¦ October 15, 2015 ¦